<DOC>
	<DOCNO>NCT02175693</DOCNO>
	<brief_summary>Investigation clinical condition safety patient cervical dystonia</brief_summary>
	<brief_title>Post-marketing Surveillance Administration Botulinum Toxin Type B ( NerBloc ) -Investigation Clinical Condition Safety Patients With Cervical Dystonia</brief_title>
	<detailed_description />
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>Torticollis</mesh_term>
	<criteria>Inclusion criterion : Patients cervical dystonia Exclusion criterion : The patient participate surveillance past</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Torticollis</keyword>
	<keyword>rimabotulinumtoxinB</keyword>
</DOC>